Home›Companies›Biotech & Pharma›Neurock Pharmaceuticals

Neurock Pharmaceuticals Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 11, 2024·Suggest an edit

About Neurock Pharmaceuticals

Neurock Pharmaceuticals is a private company based in Princeton, New Jersey, incorporated in 2022 in Delaware. It has reported $10,000,000 raised in one offering on Form D since March 2024. Its chief executive is Lei Cai.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 29, 2024Mar 11, 2024$10,000,000fully sold1$10.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Neurock Pharmaceuticals's Form D filed Mar 11, 2024.

HW
Haixing Wang
Executive officer
QW
Qingxi Wang
Director
LC

Sources

  1. SECNeurock Pharmaceuticals Inc. filing history